title: [Heparin induced thrombocytopenia: how to manage when the patient is pregnant?].
abstract: Immune mediated heparin induced thrombocytopenia (HIT) remains the most common anti-body mediated, drug-induced thrombocytopenic disorder, and a leading cause of morbidity and mortality. Management of HIT in pregnant women remains uncertain. In this article, HIT in general, and special conditions and management issues in pregnant women discussed and the related literature reviewed.
authors.affiliation: Obstetrics and Gynecology, Vanderbilt University, Nashville, TN 37205, USA. dikensoy@yahoo.com
authors.forename: Ebru
authors.initials: E
authors.lastname: Dikensoy
authors.forename: Oner
authors.initials: O
authors.lastname: Dikensoy
authors.forename: Cornelia
authors.initials: C
authors.lastname: Graves
authors.forename: Richard W
authors.initials: RW
authors.lastname: Light
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects*; D005260:Female; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000139:chemically induced / Q000628:therapy*; D013921:Thrombocytopenia / Q000139:chemically induced / Q000628:therapy*
chemical_list: D000925:Anticoagulants; D006493:Heparin